Unique device identifier (udi#): in the absence of a reported part number, the udi cannot be calculated.
The device was not returned for evaluation.
A review of the lot history record could not be conducted because the part and lot number was not provided.
The reported patient effect of ischemia is listed in the xience v everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary procedures.
A conclusive cause for the reported ischemia, and the relationship to the product, if any, cannot be determined.
The treatment(s) appears to be related to the operational context of the procedure.
There is no indication of a product quality issue with respect to manufacture, design or labeling.
The additional adverse patient effect of death referenced is being filed under a separate medwatch report number.
Article titled: clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes.
|